diabetes
Diabetes is a common disease caused by the interaction of genetic and environmental factors. The main clinical sign is high blood sugar. Common symptoms include polydipsia, polyuria, polyphagia, and weight loss. Diabetes can cause damage to multiple systems in the body, leading to absolute or relative insulin deficiency and reduced insulin sensitivity of target tissue cells, causing a series of metabolic disorders such as protein, fat, water, and electrolytes. Significant increase in blood sugar can cause acute complications such as diabetic ketoacidosis and hyperosmolar coma. Long-term illness can also cause vascular and neuropathy, resulting in damage to multiple organs and tissues such as the heart, brain, kidneys, eyes, nerves, and skin, affecting the patient's quality of life and even shortening life expectancy. Active prevention and treatment should be carried out.
-
Site of disease:
Pancreas whole body -
Infectious :
Not contagious -
Frequent population:
Middle-aged people over 40 -
Related symptoms:
Polydipsia polyuria polyphagia weight loss diabetes -
Concurrent disease:
Related Drugs
Glimepiride Tablets
Indication: Type 2 diabetes.
Manufacturer:
Yangtze River Pharmaceutical Group Guangzhou Hairui Pharmaceutical Co., Ltd.
Glimepiride Tablets
Indication: Used for type 2 diabetes mellitus in which diet, physical exercise and weight loss cannot satisfactorily control blood sugar.
Manufacturer:
Chongqing Kangke'er Pharmaceutical Co., Ltd.
Glimepiride Tablets
Indication: Used for type 2 diabetes mellitus in which diet, physical exercise and weight loss cannot satisfactorily control blood sugar.
Manufacturer:
Chongqing Kangke'er Pharmaceutical Co., Ltd.
Glimepiride Tablets
Indication: Used for type 2 diabetes mellitus in which diet, physical exercise and weight loss cannot satisfactorily control blood sugar.
Glipizide Extended Release Tablets
Indication: It is suitable for patients with mild to moderate type 2 diabetes who have not achieved satisfactory results with diet control and physical exercise for 2 to 3 months. The pancreatic beta cells of such diabetic patients must have a certain insulin secretion function, and have no acute complications (such as infection trauma, ketoacidosis, hyperosmolar coma, etc.), no pregnancy, and no serious chronic complications.
Manufacturer:
Changzhou Siyao Pharmaceuticals Co., Ltd.
Glipizide Extended Release Tablets
Indication: It is suitable for patients with mild to moderate type 2 diabetes who have not achieved satisfactory results with diet control and physical exercise for 2 to 3 months. The pancreatic beta cells of such diabetic patients must have a certain insulin secretion function, and have no acute complications (such as infection trauma, ketoacidosis, hyperosmolar coma, etc.), no pregnancy, and no serious chronic complications.
Manufacturer:
Changzhou Siyao Pharmaceuticals Co., Ltd.
Glipizide Extended Release Tablets
Indication: It is suitable for patients with mild to moderate type 2 diabetes who have not achieved satisfactory results with diet control and physical exercise for 2 to 3 months. The pancreatic beta cells of such diabetic patients must have a certain insulin secretion function, and have no acute complications (such as infection, trauma, ketoacidosis, hyperosmolar coma, etc.), no pregnancy, and no serious chronic complications.
Atorvastatin Calcium Tablets
Indication: 1. Primary hypercholesterolemia and mixed hyperlipidemia, to reduce elevated TC, LDL-C, ApoB and TG levels. 2. Patients with hypercholesterolemia and risk of atherosclerosis.
Atorvastatin Calcium Tablets
Indication: 1. Hypercholesterolemia Patients with primary hypercholesterolemia, including familial hypercholesterolemia (heterozygous type) or mixed hyperlipidemia (equivalent to type IIa and IIb of Fredrickson classification), can use this product to treat elevated total cholesterol, elevated low-density lipoprotein cholesterol, elevated apolipoprotein B and elevated triglycerides if dietary therapy and other non-drug treatments are unsatisfactory. In patients with homozygous familial hypercholesterolemia, atorvastatin calcium can be used in combination with other lipid-lowering therapies (such as LDL plasma dialysis) or alone (when no other treatment is available) to lower total cholesterol and low-density lipoprotein cholesterol. 2. Coronary heart disease Coronary heart disease or coronary heart disease-related critical illnesses (such as diabetes, symptomatic atherosclerotic disease, etc.) combined with high
Manufacturer:
Beijing Jialin Pharmaceutical Co., Ltd.
Carvedilol
Indication: It is an α and β receptor blocker. It has a vasodilating effect while blocking the receptors. It is used to treat mild and moderate hypertension or hypertension patients with renal insufficiency and diabetes.
Manufacturer:
Hainan Bikai Pharmaceutical Co., Ltd.
Related Ingredients